ALCON, INC.
Patent Owner
Stats
- 16 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Jul 04, 2017 most recent publication
Details
- 16 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 7,500 Total Citation Count
- Dec 21, 1977 Earliest Filing
- 303 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9693967 Biodegradable microparticle pharmaceutical formulations exhibiting improved released ratesSep 07, 05Jul 04, 17[A61K]
9068246 Decarbonization process for carbothermically produced aluminumDec 15, 08Jun 30, 15[C22B, C21C, C21B]
7758778 Methods for preparing biodegradable microparticle formulations containing pharmaceutically active agentsSep 07, 05Jul 20, 10[A61J, B29B]
7261529 Apparatus for preparing biodegradable microparticle formulations containing pharmaceutically active agentsSep 07, 05Aug 28, 07[B29B]
7111665 Lubricant for improved surface quality of cast aluminum and methodAug 04, 05Sep 26, 06[B22D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
7780728 Correction of higher order aberrations in intraocular lensesWithdrawnMay 17, 06Aug 24, 10[A61F]
2010/0199,269 PROGRAM OPTIMIZATION DEVICE AND PROGRAM OPTIMIZATION METHODAbandonedOct 08, 08Aug 05, 10[G06F]
2010/0152,279 RNAi Inhibition of Serum Amyloid A For Treatment of GlaucomaAbandonedFeb 25, 10Jun 17, 10[A61K, A61P]
2009/0258,955 INTRAOCULAR IRRIGATING SOLUTION HAVING IMPROVED FLOW CHARACTERISTICSAbandonedApr 14, 09Oct 15, 09[A61K]
2009/0203,614 USE OF AGENTS THAT PREVENT THE GENERATION OF AMYLOID-LIKE PROTEINS AND/OR DRUSEN, AND/OR USE OF AGENTS THAT PROMOTE SEQUESTRATION AND/OR DEGRADATION OF, AND/OR PREVENT THE NEUROTOXIC EFFECTS OF SUCH PROTEINS IN THE TREATMENT OF MACULAR DEGENERATIONAbandonedApr 17, 09Aug 13, 09[A61K, A61P]
2009/0181,893 USE OF AGENTS THAT PREVENT GENERATION OF AMYLOID AND AMYLOID-LIKE LIPOPROTEINS, AND/OR USE OF AGENTS THAT PROMOTE SEQUESTRATION AND/OR DEGRADATION OF, AND/OR PREVENT NEUROTOXICITY OF SUCH PROTEINS IN THE TREATMENT OF HEARING LOSS AND IMPROVING BODY BALANCEAbandonedMar 02, 09Jul 16, 09[A61K, A61P]
2009/0181,933 USE OF STEROIDS TO TREAT PERSONS SUFFERING FROM OCULAR DISORDERSAbandonedJan 11, 08Jul 16, 09[A61K]
2009/0160,075 METHODS FOR FABRICATING CUSTOMIZED INTRAOCULAR LENSESAbandonedDec 17, 08Jun 25, 09[A61F, B29D]
2009/0164,008 LENS SURFACE WITH COMBINED DIFFRACTIVE, TORIC, AND ASPHERIC COMPONENTSAbandonedDec 21, 07Jun 25, 09[A61F]
2009/0156,693 OPHTHALMIC COMPOSITIONS CONTAINING POLYSACCHARIDE/BORATE GELLING SYSTEMAbandonedFeb 23, 09Jun 18, 09[A61K, A61P]
2009/0048,146 USE OF AGENTS THAT UPREGULATE CRYSTALLIN EXPRESSION IN THE RETINA AND OPTIC NERVE HEADAbandonedDec 21, 07Feb 19, 09[A61K, C12Q, C12N, G01N]
2009/0018,548 Pneumatically-Powered Intraocular Lens Injection Device with Removable CartridgeAbandonedJul 13, 07Jan 15, 09[A61F]
7476687 Substituted furo[2,3-g]indazoles for the treatment of glaucomaExpiredNov 24, 04Jan 13, 09[A01N]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
